NKI researchers discover three new resistance mechanisms against commonly used anti-cancer drugs


Researchers of the Netherlands Cancer Institute have discovered three new resistance mechanisms of cancer cells against the commonly used anti-cancer drugs doxorubicin and etoposide. In The Netherlands alone, thousands of patients a year are treated with one of these drugs. But they don't always work well for every patient. The new discovery might help predict whether a patient will or will not benefit from them.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.